Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 741

1.

Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.

Indraccolo S.

Adv Exp Med Biol. 2013;734:37-52. doi: 10.1007/978-1-4614-1445-2_3.

PMID:
23143974
2.

Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.

Masiero M, Minuzzo S, Pusceddu I, Moserle L, Persano L, Agnusdei V, Tosello V, Basso G, Amadori A, Indraccolo S.

Leukemia. 2011 Apr;25(4):588-98. doi: 10.1038/leu.2010.323. Epub 2011 Jan 25.

PMID:
21263446
3.

Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy.

Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L, Reboldi A, Favaro E, Mecarozzi M, Di Mario G, Screpanti I, Ponzoni M, Doglioni C, Amadori A.

Cancer Res. 2009 Feb 15;69(4):1314-23. doi: 10.1158/0008-5472.CAN-08-2791. Epub 2009 Feb 10.

4.

Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.

Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL.

Cancer Res. 2007 Dec 1;67(23):11244-53.

5.

Genes and regulatory pathways involved in persistence of dormant micro-tumors.

Almog N.

Adv Exp Med Biol. 2013;734:3-17. doi: 10.1007/978-1-4614-1445-2_1.

PMID:
23143972
6.

Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.

Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li JL, Harris AL.

Microvasc Res. 2008 Mar;75(2):144-54. Epub 2007 Jun 29.

PMID:
17692341
8.

Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.

Favaro E, Amadori A, Indraccolo S.

APMIS. 2008 Jul-Aug;116(7-8):648-59. doi: 10.1111/j.1600-0463.2008.01025.x. Review.

PMID:
18834409
9.

MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis.

Deng Y, Yang J, McCarty M, Su B.

Am J Physiol Cell Physiol. 2007 Oct;293(4):C1404-11. Epub 2007 Aug 8.

10.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

11.

Tumor dormancy and cancer stem cells: two sides of the same coin?

Kleffel S, Schatton T.

Adv Exp Med Biol. 2013;734:145-79. doi: 10.1007/978-1-4614-1445-2_8.

PMID:
23143979
12.

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.

Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, Wu H, Chowdhury PS, Russell AJ, Montgomery CP, Poulsom R, Harris AL.

Cancer Res. 2011 Sep 15;71(18):6073-83. doi: 10.1158/0008-5472.CAN-11-1704. Epub 2011 Jul 29.

14.

The host support niche as a control point for tumor dormancy: implications for tumor development and beyond.

Hahnfeldt P.

Adv Exp Med Biol. 2013;734:19-35. doi: 10.1007/978-1-4614-1445-2_2.

PMID:
23143973
15.

Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.

Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Watanabe A, Aburatani H, Miyoshi H, Kiyono K, Shirai YT, Suzuki HI, Hirakawa K, Kano MR, Miyazono K.

J Natl Cancer Inst. 2009 Apr 15;101(8):592-604. doi: 10.1093/jnci/djp058. Epub 2009 Apr 7.

16.

AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma.

Neurath KM, Keough MP, Mikkelsen T, Claffey KP.

Glia. 2006 May;53(7):733-43.

PMID:
16518831
17.

Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.

Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.

Chin Med J (Engl). 2008 Nov 20;121(22):2324-30.

PMID:
19080341
18.

Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.

Gacche RN, Meshram RJ.

Prog Biophys Mol Biol. 2013 Nov;113(2):333-54. doi: 10.1016/j.pbiomolbio.2013.10.001. Epub 2013 Oct 15. Review.

PMID:
24139944
19.

Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.

Straume O, Shimamura T, Lampa MJ, Carretero J, Øyan AM, Jia D, Borgman CL, Soucheray M, Downing SR, Short SM, Kang SY, Wang S, Chen L, Collett K, Bachmann I, Wong KK, Shapiro GI, Kalland KH, Folkman J, Watnick RS, Akslen LA, Naumov GN.

Proc Natl Acad Sci U S A. 2012 May 29;109(22):8699-704. doi: 10.1073/pnas.1017909109. Epub 2012 May 15.

20.

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.

Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Chester R, Jackson JA, Boffey SJ, Valentine PJ, Curwen JO, Musgrove HL, Graham GA, Hughes GD, Thomas AP, Stokes ES, Curry B, Richmond GH, Wadsworth PF, Bigley AL, Hennequin LF.

Cancer Res. 2002 Aug 15;62(16):4645-55.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk